on 02 Apr 2024
Last Applicant/ Owned by
32 Cliffwood Dr.
Allentown
NJ
08501
Serial Number
97537453 filed on 05th Aug 2022
Registration Number
7348343 registered on 02th Apr 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Software as a service (SAAS) services featuring software using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetic Read More
Software as a service (SAAS) services featuring software using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals; Platform as a service (PAAS) services featuring software platforms using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals
31st Oct 2022
14th Nov 2022
No 97537453
No Service Mark
No 4483-008TM
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
02th Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
28th Feb 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
27th Feb 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
24th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
24th Feb 2024 | STATEMENT OF USE PROCESSING COMPLETE |
01st Feb 2024 | TEAS STATEMENT OF USE RECEIVED |
01st Feb 2024 | USE AMENDMENT FILED |
12th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
17th Oct 2023 | PUBLISHED FOR OPPOSITION |